MedTrace Logo

Efficacy and Safety of Protein Product in Volunteers With Sarcopenia

NCT05869305 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-05-24

No results posted yet for this study

Summary

The objective of this study are to evaluate efficacy and safety of protein product in volunteers with sarcopenia.

Conditions

Interventions

DIETARY_SUPPLEMENT

whey protein isolate

Take 1 sachet/day for 12 weeks.

DIETARY_SUPPLEMENT

isolated soy protein

Take 1 sachet/day for 12 weeks.

DIETARY_SUPPLEMENT

placebo

Take 1 sachet/day for 12 weeks.

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-02-01
Completion
2024-03-20

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05869305 on ClinicalTrials.gov